Photo: Tadeusz Zachwieja / Unsplash
Vincristine and vinblastine from the Madagascar rose periwinkle - the established pharmaceutical precedent that makes 12,000+ unsequenced endemic species commercially compelling.
Photo: Tadeusz Zachwieja / Unsplash
Catharanthus roseus - the rose periwinkle - is endemic to Madagascar's coastal and spiny thicket zones. It is the source of vincristine and vinblastine: two vinca alkaloids on the WHO Essential Medicines List that are cornerstones of childhood leukaemia and Hodgkin lymphoma treatment. Their combined lifetime revenues run to tens of billions of dollars. Madagascar received nothing.
This is not ancient history. It is the documented commercial reality that the Nagoya Protocol was designed to address - and that IsoGentiX's compliance infrastructure makes legally irreversible for future discoveries.
The argument for 11,991 other species: Catharanthus roseus is one of nine Madagascar endemic plant species with a full public genome. The chemistry that produced vincristine emerged from a single species in a single family. The eastern rainforest alone contains dozens of Apocynaceae genera, thousands of endemic species, and alkaloid biosynthetic machinery that has never been systematically explored at the genomic level. The precedent is established. The opportunity is the 99.92% that remains.
The rose periwinkle was collected from Madagascar in the 1950s and 1960s without government consent, without community consultation, and without any benefit-sharing agreement. The compounds were patented and commercialised by Eli Lilly without any return to Madagascar or its communities. This remains one of the most cited examples of biopiracy in the ethnobotanical literature.
EU ABS Regulation 511/2014, enacted in direct response to cases like this, now creates enforceable legal liability for any European company accessing genetic resources without documented PIC/MAT provenance. The era of zero-cost tropical biological extraction is over. The only clean legal pathway to Madagascar's biological intelligence is through an institution that has built the compliance infrastructure - and that is IsoGentiX.